Home/Captura Biopharma/Anthony Soscia

AS

Anthony Soscia

President, Co-Founder

Captura Biopharma

Therapeutic Areas

Radiation Emergency Medicine Medical Countermeasures

Captura Biopharma Pipeline

Drug	Indication	Phase
C2E2	Treatment of internal radioactive contamination (e.g., from nuclear accidents, radiological incidents)	Pre-clinical

Leadership Team at Captura Biopharma

Michael B. Geranen

CEO, Co-Founder

Dr. Gary Barnette, Ph.D.

Dr. Peter Paganussi, M.D.

Chief Medical Officer

View full Captura Biopharma profile